Lyell Immunopharma
LYEL
$2.25
Share price
3.69%
Change (1 day)
5.14%
Change (1 year)
Categories
P/S ratio for Lyell Immunopharma (LYEL)
P/S ratio as of April 2024 (TTM): > 1000
According to Lyell Immunopharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4412.37. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Lyell Immunopharma from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 36690.21% |
| 2022 | 10.2 | -94.15% |
| 2021 | 175 |